Vanguard Capital Management’s Biofrontera BFRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$91.7K Buy
84,880
+13,500
+19% +$17K ﹤0.01% 3858
2026
Q2
$67.5K Buy
71,380
+19,126
+37% +$18.9K ﹤0.01% 3912
2026
Q1
$42.3K Buy
+52,254
New +$45K ﹤0.01% 3934

Other funds holding BFRI

Vanguard Capital Management's BFRI Position: Q3 2026 in Review

Vanguard Capital Management increased its Biofrontera (BFRI) stake by 19% in Q3 2026, buying an estimated $17K and bringing the position to 84,880 shares worth $91.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3858.

Vanguard Capital Management first reported a position in BFRI in Q1 2026 and has held it in 3 quarters since. 20 funds tracked by Wall St. Rank hold BFRI as of Q3 2026.

  • Vanguard Capital Management held 84,880 shares of Biofrontera worth $91.7K as of Q3 2026.
  • Vanguard Capital Management bought 13,500 Biofrontera shares in Q3 2026, an estimated $17K.
  • Biofrontera made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3858 holding.
  • Vanguard Capital Management first reported a position in Biofrontera in Q1 2026 and has held it in 3 quarters since.
  • 20 funds tracked by Wall St. Rank held Biofrontera as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.